DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for hereditary gingival fibromatosis — screening already-approved drugs against its 3-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleHereditary gingival fibromatosis maps to a 3-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for hereditary gingival fibromatosis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
SOS Ras/Rac guanine nucleotide exchange factor 1 (SOS1) — SOS1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 3KSY · 3.178 Å · ligand none (apo structure). Experimental structure, not a prediction.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Zenodo (CERN European Organization for Nuclear Research) · 2021 · 0 citations · open access
HEREDITARY GINGIVAL FIBROMATOSIS: CLINICAL CASES AND LITERATURE REVIEW
Abstract<p>Gingival fibromatosis (GF) is characterized by a slow and progressive proliferation that can affect the marginal and attached gingiva, or the inter-dental papillae. This condition can be localized or generalized, with varying degrees of severity.GF may develop in susceptible individuals as a side effect of systemic medications or as idiopathic gingival fibromatosis. It may also be related to hereditary factors and occurs as a non-syndromic hereditary gingival fibromatosis or as a part of a syndrome.Our aim is to describe trought four cases of hereditary gingival fibromatosis and a literature review the clinical features,etiopathogenesis, histopathological characteristics and treatment of this condition.</p>\n\n<p> </p>
International Journal of Applied Dental Sciences · 2021 · 0 citations · open access
Gingival fibromatosis: A case report
AbstractGingival fibromatosis (GF) is a rare and diverse group of illnesses characterised by slow-growing, localised or diffuse gingival and interdental papilla enlargements. Extra tissue may cover the crowns of the teeth due to the development of pseudo pockets and plaque collecting, causing functional, cosmetic, and periodontal issues including as bone loss and bleeding. It affects both men and women equally. Hereditary, drug-induced, and idiopathic factors have all been associated to gingival overgrowth. Gingival fibromatosis is a hereditary condition that can occur on its own or as part of a bigger genetic disorder. Gingival fibromatosis is characterised by an excessive build-up of extracellular matrix proteins, the most visible of which is collagen type I. A mutation in the son-of-Sevenless-1 gene has been proposed as one possible etiological cause of solitary (non-syndromic) hereditary gingival fibromatosis, given the disorder's variability. Other genes, on the other hand, are likely to be involved. The patient's medical history and clinical symptoms, as well as a histological study of the affected gingiva, are used to make the diagnosis. Early finding is crucial, especially when it comes to excluding oral cancer. The differential diagnosis includes all oral illnesses with substantial gingival overgrowth. Treatments vary based on the type of overgrowth and the degree of disease progression; for example, scaling the teeth is sufficient in moderate cases, but surgical intervention is required in severe cases. The prognosis is unknown, and recurrence is possible.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
